UnknownNot Applicable

Potassium Titanyl Phosphate Laser Versus Pulsed Dye Laser for Rosacea - a Prospective Study

Germany30 participantsStarted 2023-02-01

Plain-language summary

To compare the efficacy and safety of 532 nm KTP and 585 nm PDL for treating rosacea.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men and women 18 years and older * Good general health, no relevant previous diseases * Presence of rosacea * Cognitive ability and willingness to give consent (Informed Consent) Exclusion Criteria: * Age \< 18 years * Pregnant and breastfeeding women * Significant open wounds or lesions of the region to be treated * Metallic implants in the region to be treated * Missing consent and/or data protection declarations

What they're measuring

reduction of erythema

Timeframe: at follow-up visit 4 weeks after last treatment session

pain intensity

Timeframe: at follow-up visit 4 weeks after last treatment session

swelling

Timeframe: at follow-up visit 4 weeks after last treatment session

purpura

Timeframe: at follow-up visit 4 weeks after last treatment session

Trial details

NCT IDNCT05771298

SponsorUniversitätsklinikum Hamburg-Eppendorf

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-05-01

Contact for this trial

L Nguyen, MD

+49 (0)40 7410-0 l.nguyen@uke.de

View on ClinicalTrials.gov More Rosacea trials